CN119235864A - 取代的哌啶化合物及其用途 - Google Patents

取代的哌啶化合物及其用途 Download PDF

Info

Publication number
CN119235864A
CN119235864A CN202411459551.4A CN202411459551A CN119235864A CN 119235864 A CN119235864 A CN 119235864A CN 202411459551 A CN202411459551 A CN 202411459551A CN 119235864 A CN119235864 A CN 119235864A
Authority
CN
China
Prior art keywords
azabicyclo
mmol
compound
added
oct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202411459551.4A
Other languages
English (en)
Chinese (zh)
Inventor
吉田融
北阳一
小竹真
反町启一
大房俊行
元木贵史
浅羽太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanitary Material R&d Management Co ltd
Original Assignee
Sanitary Material R&d Management Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanitary Material R&d Management Co ltd filed Critical Sanitary Material R&d Management Co ltd
Publication of CN119235864A publication Critical patent/CN119235864A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pain & Pain Management (AREA)
CN202411459551.4A 2020-07-17 2021-07-15 取代的哌啶化合物及其用途 Pending CN119235864A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2020122864 2020-07-17
JP2020-122864 2020-07-17
CN202180044081.3A CN115884971B (zh) 2020-07-17 2021-07-15 取代的哌啶化合物及其用途
PCT/JP2021/026649 WO2022014680A1 (ja) 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202180044081.3A Division CN115884971B (zh) 2020-07-17 2021-07-15 取代的哌啶化合物及其用途

Publications (1)

Publication Number Publication Date
CN119235864A true CN119235864A (zh) 2025-01-03

Family

ID=79291962

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202411459551.4A Pending CN119235864A (zh) 2020-07-17 2021-07-15 取代的哌啶化合物及其用途
CN202411462171.6A Pending CN119258067A (zh) 2020-07-17 2021-07-15 取代的哌啶化合物及其用途
CN202180044081.3A Active CN115884971B (zh) 2020-07-17 2021-07-15 取代的哌啶化合物及其用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN202411462171.6A Pending CN119258067A (zh) 2020-07-17 2021-07-15 取代的哌啶化合物及其用途
CN202180044081.3A Active CN115884971B (zh) 2020-07-17 2021-07-15 取代的哌啶化合物及其用途

Country Status (32)

Country Link
US (1) US11479552B2 (cg-RX-API-DMAC7.html)
EP (1) EP4151277B1 (cg-RX-API-DMAC7.html)
JP (1) JP7190612B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230040953A (cg-RX-API-DMAC7.html)
CN (3) CN119235864A (cg-RX-API-DMAC7.html)
AR (1) AR122973A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021308053A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022026161A2 (cg-RX-API-DMAC7.html)
CA (1) CA3187835A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022003666A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022018446A2 (cg-RX-API-DMAC7.html)
DK (1) DK4151277T3 (cg-RX-API-DMAC7.html)
ES (1) ES3067008T3 (cg-RX-API-DMAC7.html)
FI (1) FI4151277T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20260428T1 (cg-RX-API-DMAC7.html)
IL (1) IL299125B2 (cg-RX-API-DMAC7.html)
JO (1) JOP20220345A1 (cg-RX-API-DMAC7.html)
LT (1) LT4151277T (cg-RX-API-DMAC7.html)
MA (1) MA59554B1 (cg-RX-API-DMAC7.html)
MD (1) MD4151277T2 (cg-RX-API-DMAC7.html)
MX (1) MX2022016388A (cg-RX-API-DMAC7.html)
PE (1) PE20231103A1 (cg-RX-API-DMAC7.html)
PH (1) PH12022553488A1 (cg-RX-API-DMAC7.html)
PL (1) PL4151277T3 (cg-RX-API-DMAC7.html)
PT (1) PT4151277T (cg-RX-API-DMAC7.html)
RS (1) RS67943B1 (cg-RX-API-DMAC7.html)
SI (1) SI4151277T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202600159T1 (cg-RX-API-DMAC7.html)
TW (2) TWI888599B (cg-RX-API-DMAC7.html)
UA (1) UA129636C2 (cg-RX-API-DMAC7.html)
WO (1) WO2022014680A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202213562B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260083444A (ko) 2019-11-25 2026-06-05 알케르메스,인코포레이티드 치환된 마크로사이클릭 화합물 및 관련 치료 방법
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
JP7833486B2 (ja) 2021-05-26 2026-03-19 アルカーメス,インコーポレイテッド 置換されるカルバメート大環状化合物および関連のある治療方法
JP7591592B2 (ja) * 2022-01-14 2024-11-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物を含有する医薬
WO2023136279A1 (ja) * 2022-01-14 2023-07-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物の結晶並びに置換ピペリジン化合物の塩及びそれらの結晶
EP4600242A1 (en) * 2022-10-07 2025-08-13 Kissei Pharmaceutical Co., Ltd. Cyclopentane compound
TW202432109A (zh) * 2022-10-31 2024-08-16 日商武田藥品工業股份有限公司 食慾素2型受體促效劑之給藥
JPWO2024128305A1 (cg-RX-API-DMAC7.html) 2022-12-16 2024-06-20
TW202502342A (zh) 2023-06-02 2025-01-16 日商武田藥品工業股份有限公司 食慾素2受體促效劑用於改善睡眠期間之呼吸功能的用途
CN122374291A (zh) 2023-12-12 2026-07-10 爱杜西亚药品有限公司 作为食欲素受体调节剂的芳基砜及砜酮衍生物
WO2025132542A1 (en) 2023-12-19 2025-06-26 Idorsia Pharmaceuticals Ltd Macrocyclic orexin agonists
WO2025137359A1 (en) 2023-12-20 2025-06-26 Eisai R&D Management Co., Ltd. Assay methods to identify a disease
WO2025229493A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
EP0828751A4 (en) 1995-05-05 1999-01-20 Human Genome Sciences Inc HUMAN NEUROPEPTIDE RECEPTOR
US6309854B1 (en) 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US5935814A (en) 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
WO2005028438A1 (ja) 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. 新規ピペリジン誘導体
AU2005298693A1 (en) * 2004-10-20 2006-05-04 Neurosearch A/S Novel diazabicyclic aryl derivatives and their medical use
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
TW201444849A (zh) * 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途

Also Published As

Publication number Publication date
LT4151277T (lt) 2026-04-10
CN115884971A (zh) 2023-03-31
UA129636C2 (uk) 2025-06-18
BR112022026161A2 (pt) 2023-01-31
IL299125A (en) 2023-02-01
ZA202213562B (en) 2023-10-25
MX2022016388A (es) 2023-01-30
JP7190612B2 (ja) 2022-12-15
MA59554B1 (fr) 2026-04-30
CO2022018446A2 (es) 2023-03-07
IL299125B2 (en) 2026-03-01
ES3067008T3 (en) 2026-05-19
CL2022003666A1 (es) 2023-05-26
WO2022014680A1 (ja) 2022-01-20
EP4151277B1 (en) 2026-01-28
PH12022553488A1 (en) 2024-04-22
SMT202600159T1 (it) 2026-05-12
CN115884971B (zh) 2024-11-05
DK4151277T3 (da) 2026-04-13
JOP20220345A1 (ar) 2022-12-21
TWI922338B (zh) 2026-04-11
AU2021308053A1 (en) 2023-02-02
JPWO2022014680A1 (cg-RX-API-DMAC7.html) 2022-01-20
SI4151277T1 (sl) 2026-05-29
MD4151277T2 (ro) 2026-05-31
IL299125B1 (en) 2025-11-01
FI4151277T3 (fi) 2026-03-27
TWI888599B (zh) 2025-07-01
TW202216705A (zh) 2022-05-01
HRP20260428T1 (hr) 2026-05-08
US11479552B2 (en) 2022-10-25
KR20230040953A (ko) 2023-03-23
RS67943B1 (sr) 2026-04-30
PE20231103A1 (es) 2023-07-19
PL4151277T3 (pl) 2026-05-25
EP4151277A1 (en) 2023-03-22
EP4151277A4 (en) 2024-06-26
CN119258067A (zh) 2025-01-07
AR122973A1 (es) 2022-10-19
CA3187835A1 (en) 2022-01-20
TW202542144A (zh) 2025-11-01
US20220017517A1 (en) 2022-01-20
PT4151277T (pt) 2026-04-06

Similar Documents

Publication Publication Date Title
CN115884971B (zh) 取代的哌啶化合物及其用途
TWI378101B (en) Pyridine derivatives and their use in the treatment of psychotic disorders
ES2609264T3 (es) Formas sólidas que comprenden (-)-O-desmetilvenlafaxina y usos de las mismas
TW201018663A (en) Fluorene compound and pharmaceutical use thereof
TW202340145A (zh) 氘化有機化合物及其用途
KR101800140B1 (ko) 벤조티아졸론 화합물
EP4438602A1 (en) Crystal of substituted piperidine compound, salts of substituted piperidine compound, and crystals thereof
JP7591592B2 (ja) 置換ピペリジン化合物を含有する医薬
RU2840772C1 (ru) Замещенные пиперидиновые соединения и их применение
HK40083601A (en) Substituted piperidine compound and application thereof
EA045865B1 (ru) Замещенные пиперидиновые соединения и их применение
CN108368118B (zh) 一种取代的稠合咪唑环化合物及其药物组合物
HK40083601B (en) Substituted piperidine compound and application thereof
CA2882877A1 (en) Salts of benzothiazolone compound as beta-2-adrenoceptor agonist

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination